Global Facial Injectables Market

Facial Injectables Market Size, Share, Growth Analysis, By Type(Botulinum Toxin, Collagen), By Application(Wrinkle Reduction, Facelift), By End-User(Hospitals, Ambulatory Surgery Centers) - Industry Forecast 2024-2031

Report ID: SQMIG35I2287 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 100 | Figures: 76

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Facial Injectables Market size was valued at USD 16.1 billion in 2019 and is poised to grow from USD 17.56 billion in 2023 to USD 34.49 billion by 2031, growing at a CAGR of 9.1% in the forecast period (2024-2031).

The Facial Injectables market is relatively fragmented, with a high level of competition. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions. 'Allergan', 'Galderma S.A.', 'Merz Pharma', 'Sanofi S.A.', 'Sinclair Pharma', 'Suneva Medical', 'Teoxane Laboratories', 'Anika Therapeutics', 'Anteis S.A.', 'BioPolymer GmbH & Co. KG', 'Cynosure, Inc.', 'Ipsen Group', 'Medytox, Inc.', 'Polymekon s.r.o.', 'Prollenium Medical Technologies Inc.', 'Q-Med AB', 'Revance Therapeutics, Inc.', 'SciVision Biotech Inc.', 'Syneron Medical Ltd.', 'VisionMed Inc.'

Skin damage is caused by environmental pollutants and varied lifestyle choices, which raises its demand during the projection period. Facial injectables are composed of collagen fibres, hyaluronic acid fillers, and synthetic fillers.

Male Population to Highly Adopt Facial Injectables: An upsurge in the adoption of facial injectables among the male population is one of the key trends in the market. Throughout the forecast period, the male population is anticipated to embrace a variety of fillers, including botulinum toxin and dermal fillers. For instance, young men choose tissue fillers as an anti-aging agent. This is likely to upsurge the adoption of facial injectables among the male population.

North America held the largest share of the facial Injectables market due to the high demand for aesthetic procedures; Followed by Europe due to the high amount of cosmetic operations in the region, such as botulinum toxin type A and different dermal fillers. Furthermore, new product releases in the region by companies with high expenditure patterns are projected to fuel the market in coming years.

Related Reports

Microbiome Therapeutics Market
Buy Now GET FREE SAMPLE
Prenatal Vitamin Supplement Market
Buy Now GET FREE SAMPLE
Viral Clearance Market
Buy Now GET FREE SAMPLE
Oncology Clinical Trials Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Facial Injectables Market

Product ID: SQMIG35I2287

$5,300
BUY NOW